The most important financial indicators for the company Napoca Diab Med S.r.l. - Unique Identification Number 21526890:
sales in 2023 was
95.748
euro, registering a net profit of
73.773
euro and having an average number of
2
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 37.1%, from 70.050 euro in the year 2022, to 95.748 euro in 2023.
The Net Profit increased by 28.235 euro, from 45.676 euro in 2022, to 73.773 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Napoca Diab Med S.r.l. - CUI 21526890
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
18.429
18.485
18.427
18.845
19.210
19.589
-
20.299
20.508
20.338
Current Assets
77.539
55.600
55.033
-
192
64.506
107.034
173.341
197.513
126.001
Inventories
712
0
0
-
0
0
0
0
0
0
Receivables
68.657
55.542
54.975
-
136
14.150
8.358
24.328
64.695
71.618
Cash
8.170
58
57
-
56
50.356
98.676
149.013
132.817
54.382
Shareholders Funds
64.199
76.107
75.331
-
19.781
74.007
103.192
167.329
213.524
135.027
Social Capital
45
45
45
-
43
42
41
40
40
40
Debts
33.678
0
0
-
0
9.709
22.687
24.439
2.474
9.403
Income in Advance
0
0
0
-
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
126.001 euro in 2023 which includes Inventories of
0 euro, Receivables of
71.618 euro and cash availability of
54.382 euro.
The company's Equity was valued at
135.027 euro, while total Liabilities amounted to
9.403 euro.
Equity decreased by -77.850 euro, from 213.524 euro in 2022, to 135.027 in 2023.
Activate a subscription with unlimited access and get contact details for any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Recurring
- monthly payment
Pay
25,21EUR / month
NELIMITAT
Reports that can be accessed based on the subscription:
✔ Financial Rating
✔ Payment Limits
✔ Outstanding Debts
✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
